Yago Pico de Coaña
Bachelor’s Degree in Biology and PhD in Molecular Biology from Universidad Autónoma de Madrid. His research career started in Colombia, working with animal models related to malaria vaccine development. He went on to obtain his PhD in the Centro de Biología Molecular “Severo Ochoa” in Madrid, with a focus on the development of new strategies for allergen-specific immunotherapy. After a first postdoctoral stage in a pharmaceutical company, where he worked on new vaccine adjuvants, he moved to Sweden, to join the Cancer immune and Gene Therapy Lab in Karolinska Institute. His current line of research is focused on new immunotherapies for malignant melanoma.
He is currently a member of the board of the ACES-SFFS, the Spanish Researchers Associacion in Sweden